An application of the Toronto Childhood Cancer Stage Guidelines in three population-based cancer registries: The case of central nervous tumors.
Adolescent
Adult
Central Nervous System Neoplasms
/ mortality
Child
Child, Preschool
Data Management
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Neoplasm Staging
/ standards
Practice Guidelines as Topic
/ standards
Prognosis
Registries
/ statistics & numerical data
SEER Program
Survival Rate
Young Adult
cancer registry
central nervous cancers
childhood cancer
staging system
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
31
10
2019
revised:
11
03
2020
accepted:
16
03
2020
pubmed:
18
4
2020
medline:
18
8
2020
entrez:
18
4
2020
Statut:
ppublish
Résumé
Cancer stage is a determinant of survival of childhood central nervous system (CNS) cancers and could help the interpretation of survival variability among countries. Consensus guidelines to stage childhood malignancies in population cancer registries ("Toronto Childhood Cancer Stage Guidelines") have been recently proposed with the goal of data comparability. Indeed, stage is not systematically recorded in all registries and, when it is, different classification systems are used. We applied the Toronto Childhood Cancer Stage Guidelines to CNS cancer cases of three population-based cancer registries with the aim of evaluating the feasibility of staging this type of cancer and the critical points in the classification of CNS tumors. The Toronto Childhood Cancer Stage Guidelines were applied to 175 CNS patients, diagnosed from January 1, 2002 to December 31, 2014 in three cancer registries in Italy, and the percentage of cases that could be staged was assessed. One hundred eight of 126 (86%) medulloblastomas and other embryonal CNS cancers and 22 of 49 (45%) ependymomas were staged. Using these guidelines, survival of children with localized tumors could be discriminated from that of children with metastatic disease. The use of the Toronto Childhood Cancer Stage Guidelines is feasible for staging medulloblastoma in Italian population-based cancer registries, whereas it is more difficult for ependymomas. In Italy, cerebrospinal fluid examination, one of the decisive tests to stage CNS tumors, is not routinely performed as a first-line diagnosis procedure in ependymoma pediatric patients. A similar exercise by a larger number of cancer registries in different countries could suggest improvements in the childhood cancer staging system.
Sections du résumé
BACKGROUND
Cancer stage is a determinant of survival of childhood central nervous system (CNS) cancers and could help the interpretation of survival variability among countries. Consensus guidelines to stage childhood malignancies in population cancer registries ("Toronto Childhood Cancer Stage Guidelines") have been recently proposed with the goal of data comparability. Indeed, stage is not systematically recorded in all registries and, when it is, different classification systems are used. We applied the Toronto Childhood Cancer Stage Guidelines to CNS cancer cases of three population-based cancer registries with the aim of evaluating the feasibility of staging this type of cancer and the critical points in the classification of CNS tumors.
PROCEDURES
The Toronto Childhood Cancer Stage Guidelines were applied to 175 CNS patients, diagnosed from January 1, 2002 to December 31, 2014 in three cancer registries in Italy, and the percentage of cases that could be staged was assessed.
RESULTS
One hundred eight of 126 (86%) medulloblastomas and other embryonal CNS cancers and 22 of 49 (45%) ependymomas were staged. Using these guidelines, survival of children with localized tumors could be discriminated from that of children with metastatic disease.
CONCLUSIONS
The use of the Toronto Childhood Cancer Stage Guidelines is feasible for staging medulloblastoma in Italian population-based cancer registries, whereas it is more difficult for ependymomas. In Italy, cerebrospinal fluid examination, one of the decisive tests to stage CNS tumors, is not routinely performed as a first-line diagnosis procedure in ependymoma pediatric patients. A similar exercise by a larger number of cancer registries in different countries could suggest improvements in the childhood cancer staging system.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28303Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Gatta G, Peris-Bonet R, Visser O, et al. Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer. 2017;82:137-148.
Gupta S, Aitken JF, Bartels U, et al. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. Lancet Oncol. 2016;17(4):e163-e172.
Brierley J, Gospodarowicz M, Wittekind C. The TNM Classification of Malignant Tumours. 8th ed Oxford, UK: Hoboken, NJ: John Wiley and Sons Inc; 2017.
Greene FL, Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol. 2009;99(5):269-272.
Thompson EM, Hielscher T, Bouffet E, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016;17(4):484-495.
Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469-474.
Cairns J. Pediatric medulloblastomas: classification, therapeutics, and management. UBCMJ. 2018;9.2(8-11).
Korshunov A, Witt H, Hielscher T, et al. Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol. 2010;28(19):3182-3190.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. Revised 4th ed. WHO Press, 1211 Geneva 27, Switzerland WHO Classification of Tumours. Vol. 1. 2016.
https://seer.cancer.gov/tools/ssm/SSM2018-BRAIN.pdf. Accessed February 12, 2020.
Isaevska E, Manasievska M, Alessi D, et al. Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011. PLoS One. 2017;12(7):e0181805.
Steliarova-Foucher E, Colombet M, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18(6):719-731.
www.santobonopausilipon.it/content/registro-tumori-infantili-regione-campania-rtic
Chang CH, Housepian EM. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351.
Harisiadis L, Chang CH. Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys. 1977;2(9-10):833-841.
Aitken JF, Youlden DR, Moore AS, et al. Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study. Lancet Child Adolesc Health. 2018;2(3):173-179.
Zacharoulis S, Moreno L. Ependymoma: an update. J Child Neurol. 2009;24(11):1431-1438.
Fangusaro J, Van Den Berghe C, Tomita T, et al. Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma. J Neuroncol. 2011;103(3):693-698.
Moreno L, Pollack IF, Duffner PK, et al. Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma. J Pediatr Hematol Oncol. 2010;32(6):515-518.
Massimino M, Biassoni V, Gandola L, et al. Childhood medulloblastoma. Crit Rev Oncol Hematol. 2016;105:35-51.
Gatta G, Botta L, Trama A, Pritchard-Jones K, The Pilot Study Group. The stage for childhood cancers: the JARC pilot study. Oral communication at the ENCR Scientific Meeting and General Assembly, 26-28 September 2018, Copenhagen, Denmark.